Atrial Fibrillation in the Era of Emerging Cancer Therapies

Eur Heart J. 2019 Sep 21;40(36):3007-3010. doi: 10.1093/eurheartj/ehz649.
No abstract available

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Antineoplastic Agents / adverse effects
  • Atrial Fibrillation / complications*
  • Atrial Fibrillation / drug therapy
  • Clinical Trials as Topic
  • Drug Interactions
  • Hemorrhage / chemically induced
  • Humans
  • Neoplasms / complications*
  • Neoplasms / drug therapy
  • Practice Guidelines as Topic
  • Prognosis
  • Stroke / prevention & control
  • Thromboembolism / prevention & control

Substances

  • Anticoagulants
  • Antineoplastic Agents